6 May 2021Core One (COOL.C) subsidiary Akome begins development on psychedelic treatment…Piers Eaton COOL.C Core One Labs (COOL.C) announced their wholly-owned subsidiary, Akome Biotech, has begun the development of its patent-pending psychedelic drug formulation for the treatment of Alzheimer’s Disease. Akome’s “next-generation” psychedelic…